Introduction
============

Estradiol (E~2~) is a vital regulator of female reproduction. In addition to trophic effects of E~2~ on breast, ovarian, and uterine tissue, E~2~ plays a key role in regulating the function of gonadotropin-releasing hormone (GnRH) neurons in the hypothalamus and gonadotrophs in the pituitary throughout the female reproductive cycle. E~2~ released from the ovary induces positive and negative feedback effects on GnRH neurons in the hypothalamus. Historically, it has been viewed that E~2~ controls the GnRH neuronal system through interneurons or glial cells (Herbison, [@B33]), because earlier studies with autoradiography combined with immunocytochemistry showed that GnRH neurons do not contain nuclear estrogen receptors (ER; Shivers et al., [@B77]), whereas interneurons, such as those synthesizing neuropeptide Y (NPY), catecholamines, glutamate, GABA, and kisspeptin express nuclear ER (Stumpf and Jennes, [@B81]; Leranth et al., [@B56]; Smith et al., [@B79]; Franceschini et al., [@B25]).

After the discovery of ERβ (Kuiper et al., [@B50]), several studies found that ERβ colocalizes in GnRH neurons in several species including mice, rats, sheep, and humans (Hrabovszky et al., [@B37], [@B38], [@B36]; Herbison and Pape, [@B35]; Sharifi et al., [@B76]; Skinner and Dufourny, [@B78]). More recently, direct action of E~2~ on GnRH neurons has been shown by several groups including our own (Abrahám et al., [@B4]; Temple et al., [@B84]; Abe and Terasawa, [@B3]; Abe et al., [@B2]; Chu et al., [@B11]; Noel et al., [@B62]; Sun et al., [@B82]). Direct action of E~2~ is rapid, mediated through receptors associated with the plasma membrane, and seen in many types of neurons (Terasawa et al., [@B89]). In this article, we will review the mechanism of rapid, direct action of E~2~ on GnRH neuronal activity and possible implications of direct E~2~ action, focusing on our studies in non-human primates.

Models for Studying Direct E~2~ Action in GnRH Neurons
======================================================

The number of GnRH neurons in the brain is small and they are diffusely distributed in the preoptic area and basal hypothalamus. Thus, to study cellular and molecular mechanisms of E~2~ action in GnRH neurons we need to utilize a relatively simple population of GnRH neurons that can be directly visualized. To date three *in vitro* models have been described (Terasawa, [@B85]): (1) GT-1 and GN11 cell lines (Mellon et al., [@B59]; Radovick et al., [@B70]), (2) cultured GnRH neurons derived from the nasal placode regions in monkeys, sheep, rats, and mice (Terasawa et al., [@B90]; Daikoku and Koide, [@B15]; Fueshko and Wray, [@B27]; Duittoz et al., [@B18]), and (3) sliced preoptic-hypothalamic green fluorescent protein (GFP) labeled mouse GnRH neurons (Spergel et al., [@B80]; Suter et al., [@B83]) or mouse and guinea pig GnRH neurons identified with single cell RT-PCR or immunocytochemistry (Lagrange et al., [@B54]; Zhang et al., [@B99]). In these models, demonstration of pulsatile GnRH release or periodic activity recorded from GnRH neurons is essential, because GnRH neurons release the decapeptide hormone into the pituitary portal circulation in a pulsatile manner (Knobil, [@B45]; Gearing and Terasawa, [@B29]; Kokoris et al., [@B46]) and this pulsatility is crucial for the maintenance of normal reproductive function (Knobil, [@B45]). Importantly, the pulse frequency of GnRH release or periodic activity in a model should reflect the species origin of these GnRH neurons. In the GT-1 cells and cultured GnRH neurons, pulsatile release of GnRH peptide with species specific frequency (i.e., 20--30 min in mouse and rats, 40--60 min in sheep and monkeys) has been shown (Krsmanovic et al., [@B49]; Martinez de la Escalera et al., [@B58]; Wetsel et al., [@B94]; Terasawa et al., [@B86]; Duittoz and Batailler, [@B17]; Funabashi et al., [@B28]; Constantin et al., [@B13]). In GFP-labeled mouse GnRH neurons and GT-1 cells, periodic burst firing activity similar to GnRH pulses has also been reported (Costantin and Charles, [@B14]; Nunemaker et al., [@B63]). Among these three models, we have been using cultured GnRH neurons derived from the embryonic nasal placode of rhesus monkey fetuses, which are obtained from time-mated pregnancies (Terasawa et al., [@B90]). These GnRH neurons exhibit a spontaneous oscillatory pattern of \[Ca^2+^\]~i~ levels with variable peak amplitude and duration of each oscillation unique to each cell (Terasawa et al., [@B87]). On average, the interpulse interval between \[Ca^2+^\]~i~ oscillations is 8 min with synchronization of \[Ca^2+^\]~i~ oscillations among GnRH neurons occurring at ∼60 min intervals (Terasawa et al., [@B87]) and release GnRH peptide also at ∼60 min intervals (Terasawa et al., [@B86]). Using our cultured primate GnRH neuron model we have reported several important discoveries (see Terasawa et al., [@B89]; Terasawa et al., [@B88]). Based on comprehensive comparisons between the embryonic GnRH neuron model (in both monkeys and mice) and GFP-labeled mice GnRH neuron model, Jasoni et al. ([@B39]) and Constantin ([@B12]) conclude that physiological characteristics of the two models are quite similar.

E~2~ Rapidly Stimulates Firing Activity, Intracellular Calcium Oscillations, and GnRH Release
=============================================================================================

To determine if E~2~ causes direct action in primate GnRH neurons, we first examined the effects of E~2~ on firing activity. Application of E~2~ (1 nM) to cultured primate GnRH neurons for 10 min, induces a 250% increase in action potential firing frequency, an increase in the number of action potentials per burst, and an increase in burst duration (Abe and Terasawa, [@B3]). E~2~, however, did not change the timing of bursts (interburst interval) nor did it alter the cluster pattern, suggesting that E~2~ modulates overall firing intensity, but not the firing pattern.

Release of GnRH is also modulated by E~2~. In primate GnRH neurons, exposure to 1 nM E~2~ for 20 min results in a rapid increase of GnRH peptide release, which is initiated within 10 min of E~2~ application and lasts for 40 min (Noel et al., [@B62]). In GT-1 cells, it has been reported that exposure to a picomolar dose of E~2~ for 4 h suppresses the frequency of GnRH release (Navarro et al., [@B61]). However, the mechanism of E~2~ action between these two studies may differ, as the E~2~ exposure time in the study of GT-1 cells is much longer and may lead to nuclear receptor mediated genomic action.

E~2~ causes potent stimulatory effects on \[Ca^2+^\]~i~ oscillations. A 10 min exposure to E~2~ at 1 nM induces a 180--200% increase in the frequency of \[Ca^2+^\]~i~ oscillations, returning to baseline levels 40--60 min after initiation of E~2~ treatment (Abe et al., [@B2]). E~2~ also increases the number of activated cells from 30 to 70%. Additionally, E~2~ stimulates the average number of synchronized \[Ca^2+^\]~i~ oscillations from 1 synchronization event/hour in control samples to ∼2.7 events/hour in E~2~ treated samples (Abe et al., [@B2]). Similar E~2~ effects on \[Ca^2+^\]~i~ oscillations have also been reported in cultured mouse GnRH neurons (Temple et al., [@B84]) and we also confirmed similar E~2~ effects in additional studies (Noel et al., [@B62]; Kenealy et al., [@B42],[@B43]). Importantly, tetrodotoxin does not change the pattern of the E~2~-induced \[Ca^2+^\]~i~ oscillations (Abe et al., [@B2]), consistent with this E~2~ action causing direct effects on GnRH neurons and not through interneurons.

Rapid Stimulatory E~2~ Action in GnRH Neurons is a Membrane-Initiated Mechanism
===============================================================================

In order to assess the mechanism of rapid E~2~ action, we have examined the effects of a plasma membrane impermeable form of E~2~, E~2~-17 hemisuccinate BSA (E~2~-BSA). E~2~-BSA (1 nM) increases the frequencies of firing activity (Abe and Terasawa, [@B3]) and \[Ca^2+^\]~i~ oscillations (Noel et al., [@B62]), and stimulates GnRH release (Noel et al., [@B62]), similar to the increase observed with E~2~, suggesting that rapid action of E~2~ occurs at the cell membrane. Moreover, exposure of GnRH neurons to the nuclear impermeable E~2~ dendrimer conjugate (EDC, 1 nM), described by Harrington et al. ([@B32]), also causes an increased frequency of \[Ca^2+^\]~i~ oscillations and elevated GnRH release (Noel et al., [@B62]), indicating that E~2~ causes rapid effects without entering the nucleus. These observations indicate that rapid excitatory E~2~ action is a membrane-initiated mechanism, and does not require genomic action of E~2~. However, the amplitude and duration of the EDC- and E~2~-BSA-induced GnRH release are smaller and shorter (Noel et al., [@B62]), indicating the presence of multiple mechanisms of E~2~ action (see below).

E~2~ Action is Not Mediated by ERα or ERβ
=========================================

In general, E~2~ action through genomic changes occurs in the order of an hour to several hours or even days. In contrast, the effects elicited by E~2~ in GnRH neurons described above, i.e., the increase in firing activity, \[Ca^2+^\]~i~ oscillations, and GnRH release, occurs at a time scale of seconds to minutes. Therefore, it is speculated that the mechanism of rapid E~2~ action differs from nuclear ER mediated genomic action.

To identify the type of ER mediating rapid E~2~ action in GnRH neurons, we first examined the role of ERα or ERβ using the ER antagonist, ICI182,780. To our surprise, ICI182,780 blocks neither the E~2~-induced \[Ca^2+^\]~i~ oscillations nor synchronization (Abe et al., [@B2]). Moreover, ICI182,780 did not influence the E~2~-induced release of GnRH peptide (Noel et al., [@B62]). Considering the results of rapid direct E~2~ action through ERβ in mouse GnRH neurons (Abrahám et al., [@B4]; Temple et al., [@B84]; Chu et al., [@B11]), we further examined E~2~'s effects in GnRH neurons, in which ERα and ERβ were respectively deleted by an siRNA knockdown approach. The results show that knockdown of ERα and ERβ do not interfere with the E~2~-induced changes in \[Ca^2+^\]~i~ oscillations nor synchronization (Kenealy et al., [@B42]), confirming our findings with ICI182,780 on \[Ca^2+^\]~i~ oscillations. Collectively, these findings suggest that ERα and ERβ are neither involved in E~2~-induced \[Ca^2+^\]~i~ oscillations nor rapid release of GnRH peptide in primate GnRH neurons.

Rapid E~2~ Action is Mediated by Multiple Receptors
===================================================

In addition to ERα and ERβ, several types of ERs, such as ER-X (Toran-Allerand et al., [@B93]), G protein coupled receptor 30 (GPR30, Thomas et al., [@B91]), and membrane ER sensitive to the diphenylacrylamide compound STX (STX-R, Qiu et al., [@B66]) participate in membrane-initiated E~2~ action. Interestingly, these membrane ERs require G-protein coupled receptor (GPCR) signaling mechanisms for estrogen action (Terasawa et al., [@B89]). Rapid action through membrane ERα and ERβ also requires a companion GPCR, metabotropic glutamate receptors (Boulware et al., [@B8], [@B7]; Grove-Strawser et al., [@B31]). In primate GnRH neurons, a GPCR is also involved in rapid E~2~ action, as pertussis toxin, a broad inhibitor of GPCR signaling, blocks the E~2~-induced changes in \[Ca^2+^\]~i~ oscillations, their synchronization, and GnRH release (Noel et al., [@B62]).

GPR30, an orphan receptor coupled to Gαs proteins, binds E~2~ (Revankar et al., [@B72]; Thomas et al., [@B92]). However, E~2~ action through GPR30 does not require ERα or ERβ, as knockdown of GPR30 in ERα and ERβ negative cancer cells blocks E~2~ action (Thomas et al., [@B92]). In cancer cell lines, E~2~ action mediated by GPR30 mobilizes Gαs to stimulate adenylyl cyclase resulting in cyclic AMP synthesis and activates Gβγ signaling resulting in transactivation of epidermal growth factor receptor (Filardo et al., [@B22], [@B23]). Importantly, unlike ER-X and STX-R, the sequence of GPR30 is known. Consequently, G1, a specific agonist for GPR30 (Bologa et al., [@B6]) and G15, a specific antagonist for GPR30 (Dennis et al., [@B16]) have been synthesized. Using these tools, we have studied the role of GPR30 in membrane-initiated E~2~ action in primate GnRH neurons and found that GPR30 is, at least in part, responsible for rapid excitatory E~2~ action. First, exposure of GnRH neurons to the GPR30 receptor agonist, G1, at 10 nM, but not 1 nM, induces an increase in \[Ca^2+^\]~i~ oscillations (Noel et al., [@B62]) and G1 at 100 nM stimulates GnRH release (Kenealy and Terasawa, unpublished observations). Second, siRNA knockdown of GPR30 completely blocks the E~2~- and EDC-induced changes in \[Ca^2+^\]~i~ oscillations and their synchronization (Noel et al., [@B62]). Third, a high dose of ICI182,780 (1 μM) alone elicits changes in \[Ca^2+^\]~i~ oscillations similar to cancer cells, in which a high dose (1 μM) of ICI182,780 is an agonist for GPR30 (Filardo et al., [@B22]). Fourth, treatment with the GPR30 antagonist G15 blocks both the E~2~-induced increase in \[Ca^2+^\]~i~ oscillations, their synchronization, and E~2~-induced GnRH release, while G15 alone showed no significant effects (Kenealy and Terasawa, unpublished observations). Finally, GPR30 colocalizes in one-third of GnRH neurons in the monkey hypothalamus (Noel et al., [@B62]).

Because (1) a higher dose of G1 and EDC is required for the induction of changes in \[Ca^2+^\]~i~ oscillations and GnRH release, as compared to E~2~ changes (1 nM) and (2) the effects of a higher dose of E~2~ (10 nM) on changes in \[Ca^2+^\]~i~ oscillations is only partly blocked by GPR30 siRNA treatment (Kenealy et al., [@B43]), we have speculated that additional membrane ERs may be involved in rapid E~2~ action. STX-R was an enticing target to pursue, as STX (1) has been shown to mediate effects in hypothalamic cells in mutant mice lacking ERα, ERβ, and GPR30 receptors (Qiu et al., [@B67], [@B68]), (2) modulates ion channels involved in membrane potential changes (Zhang et al., [@B100]), and (3) is potently inhibited by ICI182,780 (Qiu et al., [@B66]). Indeed, treatment of primate GnRH neurons with 10 nM STX induces an increase in \[Ca^2+^\]~i~ oscillations, their synchronization, and increases the percent of cells stimulated, similar to both E~2~ (1 nM) and G1 (10 nM; Kenealy et al., [@B43]). Interestingly, ICI182,780 blocks the STX-induced \[Ca^2+^\]~i~ oscillations and their synchronization. Furthermore, GPR30 knockdown does not influence the STX-induced changes in \[Ca^2+^\]~i~ oscillations and their synchronization. Finally, STX (10 and 100 nM) induces a dose dependent increase in GnRH release, although the effectiveness is smaller than that induced by E~2~ at 1 nM (Kenealy et al., [@B43]). Therefore, E~2~ action in primate GnRH neurons is mediated through multiple receptor mechanisms (see Figure [1](#F1){ref-type="fig"}). This is not limited to primate GnRH neurons: in mouse GnRH neurons, in addition to E~2~ action through ERβ (Temple et al., [@B84]) and STX--R (Zhang et al., [@B100]), E~2~ through GPR30 modulates voltage gated calcium channels (Sun et al., [@B82]). Any interaction between STX-R and other ERs including GPR30 will become clear when the molecular nature of STX-R is identified.

![**Schematic illustration of rapid estradiol (E~2~) action in primate GnRH neurons**. Exposure of primate GnRH neurons to E~2~ rapidly induces \[Ca^2+^\]~i~ oscillations and GnRH peptide release within 10 min (Noel et al., [@B62]; Kenealy et al., [@B43]). Two possible mechanisms for the rapid E~2~ action through GPR30 and STX-R are discussed in this article, although many details are yet to be clarified, which are noted by question marks in the scheme. First, E~2~ binding to GPR30 may induce activation of two intracellular pathways: 1) E~2~ activation through GPR30 depolarizes GnRH neuronal membrane via VGCCs (Sun et al., [@B82]), which allows \[Ca^2+^\]~e~ entry, resulting in CICR (Kenealy et al., [@B44]) and 2) E~2~ transactivates AC and/or ErbB pathways (Filardo et al., [@B23]), which also results in CICR. Second, E~2~ binding to STX-R appears to cause 1) activation of CICR through a PLC and IP3-R mechanism leading to \[Ca^2+^\]~i~ increase (Kenealy et al., [@B43]) and 2) activation of a PKCδ-AC-PKA mechanism resulting in hyperpolarization of the GnRH neuronal membrane through KATP channels (Zhang et al., [@B100]), which are essential for burst firing of GnRH neurons, hence neurosecretion. **Abbreviations:** AC, adenylyl cyclase; Ca^2+^, calcium; \[Ca^2+^\]~e~, extracellular Ca^2+^; \[Ca^2+^\]~i~, intracellular Ca^2+^; CICR, calcium induced calcium release; DAG, diacylglycerol; E~2~, estradiol; ER, endoplasmic reticulum; ErbB, epidermal growth factor receptor; GnRH, gonadotropin-releasing hormone neuron; GPR30, G protein coupled estrogen receptor; IP3, inositol triphosphate; IP3-R, inositol triphosphate receptor; KATP, ATP sensitive potassium channel; PIP2, phosphatidylinositol biphosphate; PKA, protein kinase A; PKCδ, Protein kinase C delta; PLC, phospholipase C; RyR, ryanodine receptor; SERCA, sarco/endoplasmic reticulum Ca^2+^ ATPase; STX-R, membrane estrogen receptor sensitive to STX; VGCC, voltage gated calcium channel.](fendo-02-00106-g001){#F1}

Physiological Significance of Rapid Action in GnRH Neurons
==========================================================

Rapid E~2~ action in hypothalamic neurons was first described nearly 40 years ago (Yagi, [@B97]; Kelly et al., [@B41]). During this period, a large number of reports on rapid steroid action in various types of neurons and in glia have been reported (Orchinik et al., [@B64]; Lagrange et al., [@B54]; Boulware et al., [@B8], [@B7]; Fehrenbacher et al., [@B21]; Grove-Strawser et al., [@B31]; Kuo et al., [@B51]; Labombarda et al., [@B53]; Lebesgue et al., [@B55]). As discussed above, "rapid" timing of E~2~ action is a membrane-initiated phenomenon, rather than "long term" E~2~ action, which requires transcription after E~2~ binds to cytoplasmic/nuclear ER. However, the physiological significance of rapid E~2~ action in the hypothalamus, and specifically within the GnRH system, remains unclear.

It is unlikely that rapid, direct, excitatory action of E~2~ plays a significant role in the classical positive and negative feedback mechanisms during the reproductive cycle. Rather, the enhancing and suppressing effects of E~2~ are mediated by ERα. First, E~2~ fails to induce LH surges in ERα knockout mice as well as in mutant mice lacking estrogen response element (ERE)-dependent ERα signaling (Glidewell-Kenney et al., [@B30]). By contrast, in ERβ knockout mice E~2~ induces LH surges (Wintermantel et al., [@B95]), although these mice had ERβ splice variants (Krege et al., [@B48]), therefore, reexamination of the role of ERβ in positive feedback in mice with complete elimination of ERβ splice variants (Antal et al., [@B5]) is still needed. Similarly, cytochrome P450 aromatase knockout (ArKO) female mice, in which estradiol is absent, have acyclic estrus cycles characterized by elevated levels of LH, FSH, and testosterone (Fisher et al., [@B24]). Second, whereas convincing evidence for the presence of ERα in GnRH neurons has not been shown, the presence of ERα in interneurons that innervate GnRH neurons, such as neurons that synthesize kisspeptin, NPY, catecholamines, glutamate, and GABA have been consistently reported (Stumpf and Jennes, [@B81]; Leranth et al., [@B56]; Smith et al., [@B79]; Franceschini et al., [@B25]). Third, positive feedback effects of E~2~ on LH surges require 16--48 h (depending on species) after its administration (Yamaji et al., [@B98]; Karsch and Foster, [@B40]) and negative feedback effects of E~2~ require a minimum of 1--2 h lasting more than 12 h in rhesus monkeys (Chongthammakun and Terasawa, [@B10]; Mizuno and Terasawa, [@B60]). While it is possible that membrane ERα signaling may be in part responsible for negative feedback effects of E~2~ on LH release, as E~2~ can suppress LH levels in mice lacking ERE-dependent ERα signaling (Glidewell-Kenney et al., [@B30]), the genomic action of E~2~ through ERα is indispensable for LH/GnRH surges. Taken together, ERα within interneurons, such as kisspeptin neurons that directly innervate GnRH neurons, play a role in E~2~'s feedback action.

Based on the classical concept of positive and negative ovarian steroid feedback, doubt has been cast on the role of rapid excitatory E~2~ action in the reproductive cycle (Herbison, [@B34]). It is still unknown whether E~2~ directly alters secretory activity of GnRH neurons *in vivo*, as to date, *in vivo* effects of E~2~ on GnRH release are tested only after systemic administration of E~2~. Accumulating evidence suggests local effects of E~2~ in various brain functions (Woolley, [@B96]). For example, a recent report in male song birds showing that forebrain E~2~ concentrations rapidly (within 30 min) increase during social interaction with females (Remage-Healey et al., [@B71]) indicating the occurrence of rapid synthesis and release of E~2~ in the brain (Saldanha et al., [@B74]). Moreover, another recent study by Konkle and McCarthy ([@B47]) reports that E~2~ levels of 20--30 pg/mg tissue are observed during the first 10 days after birth in the rat hypothalamus, regardless of the presence or absence of gonads. These observations raise the possibility that a relatively high amount of E~2~ can be synthesized and released locally and rapidly in the hypothalamus under certain physiological conditions, although local concentrations of estradiol in the monkey brain are presently unknown. Therefore, we propose the hypothesis that local E~2~ release in the hypothalamus may contribute to the activity of GnRH neurons.

As described above, our observations *in vitro* consistently show that E~2~ is a potent frequency modulator of GnRH neurons (Terasawa et al., [@B89]). Thus, we can extend our hypothesis to suggest that local E~2~ may modulate pulsatility of GnRH release in a subtle manner. Although the mechanism of pulsatile GnRH release is presently unclear, the concept that coordinated release of GnRH is due to synchronized activity among GnRH neurons is generally accepted. In fact, as a means to coordinate activity, GnRH neurons may communicate through dendro-dendritic interactions (Campbell et al., [@B9]). Because GnRH is released from the cell body and dendrites of GnRH neurons besides their neuroterminals (Fuenzalida et al., [@B26]), it is possible that rapid excitatory action of E~2~ on GnRH release may contribute to the communication within dendro-dendritic bundles and consequently, modulate pulsatile GnRH release *in vivo*.

In rhesus monkeys and sheep, prenatal treatments with testosterone, which is aromatizable to E~2~ in the brain, result in conditions similar to those of polycystic ovary syndrome (PCOS), one of the most common causes of infertility in women (Abbott et al., [@B1]; Padmanabhan et al., [@B65]). Importantly, this testosterone treatment in monkeys at a fetal age of E40-60 (early treatment), but not E100-115 (late treatment), results in LH hypersecretion, reduced hypothalamic sensitivity to negative steroid feedback, and follicular arrest with premature follicle differentiation (Dumesic et al., [@B19]), as seen in PCOS patients. Moreover, studies in humans show that PCOS women exhibit an accelerated frequency of LH pulses and presumably GnRH pulses (Marshall and Eagleson, [@B57]), indicating impairment of the GnRH pulse-generating mechanism. Importantly, the effective timing of early testosterone treatment (fetal age at E40-60) in rhesus monkeys (Dumesic et al., [@B19]) exactly corresponds to the period of GnRH neuronal maturation. After differentiation from progenitor cells at E32-34, GnRH neurons start migrating into the hypothalamus at E38 and settle down in the hypothalamus by E50 (Rønnekleiv and Resko, [@B73]; Quanbeck et al., [@B69]). In fact, this period appears critical for the maturation of GnRH neuronal function. Recently, we have shown that GnRH neurons gradually mature *in vitro* during the 3-week period, after GnRH neurons are dissected out from the nasal placode and started for culture at E36 (Kurian et al., [@B52]). It should be noted that although prenatal testosterone effects in monkeys may not solely be attributable to aromatized estrogens, it is also possible that rapid excitatory E~2~ action described in this review may reflect developmental programming influenced by maternal steroidal environments during fetal development and elevated concentrations of cortisol and androgens (Schneider et al., [@B75]; Padmanabhan et al., [@B65]; Dunn et al., [@B20]).

Conclusion
==========

E~2~ action in the brain is not limited to the classical feedback control of the GnRH neuronal system. E~2~ could be involved in excitatory and inhibitory neuronal function in the hypothalamus, as shown by Mermelstein and his colleagues in hippocampal neurons (Boulware et al., [@B8], [@B7]). Moreover, E~2~ action in GnRH neurons may be the consequence of events occurring *in utero*, such as developmental programming and sexual differentiation. Advances in technology and further detailed studies will ensure the importance of rapid action of estradiol in the hypothalamus.
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